194 related articles for article (PubMed ID: 38631213)
1. Advances in understanding and exploiting Siglec-glycan interactions.
Jame-Chenarboo Z; Gray TE; Macauley MS
Curr Opin Chem Biol; 2024 Jun; 80():102454. PubMed ID: 38631213
[TBL] [Abstract][Full Text] [Related]
2. Flow Cytometry-Based Detection of Siglec Ligands.
Schmidt EN; Jung J; Macauley MS
Methods Mol Biol; 2023; 2657():181-193. PubMed ID: 37149531
[TBL] [Abstract][Full Text] [Related]
3. Current Status on Therapeutic Molecules Targeting Siglec Receptors.
Lenza MP; Atxabal U; Oyenarte I; Jiménez-Barbero J; Ereño-Orbea J
Cells; 2020 Dec; 9(12):. PubMed ID: 33333862
[TBL] [Abstract][Full Text] [Related]
4. Siglec Signaling in the Tumor Microenvironment.
van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
Front Immunol; 2021; 12():790317. PubMed ID: 34966391
[TBL] [Abstract][Full Text] [Related]
5. Probing the binding specificities of human Siglecs by cell-based glycan arrays.
Büll C; Nason R; Sun L; Van Coillie J; Madriz Sørensen D; Moons SJ; Yang Z; Arbitman S; Fernandes SM; Furukawa S; McBride R; Nycholat CM; Adema GJ; Paulson JC; Schnaar RL; Boltje TJ; Clausen H; Narimatsu Y
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33893239
[TBL] [Abstract][Full Text] [Related]
6. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
7. Siglec Ligands.
Gonzalez-Gil A; Schnaar RL
Cells; 2021 May; 10(5):. PubMed ID: 34065256
[TBL] [Abstract][Full Text] [Related]
8. Tools to study and target the Siglec-sialic acid axis in cancer.
Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
[TBL] [Abstract][Full Text] [Related]
9. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands.
Rodrigues E; Jung J; Park H; Loo C; Soukhtehzari S; Kitova EN; Mozaneh F; Daskhan G; Schmidt EN; Aghanya V; Sarkar S; Streith L; St Laurent CD; Nguyen L; Julien JP; West LJ; Williams KC; Klassen JS; Macauley MS
Nat Commun; 2020 Oct; 11(1):5091. PubMed ID: 33037195
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate Sulfation As a Mechanism for Fine-Tuning Siglec Ligands.
Jung J; Enterina JR; Bui DT; Mozaneh F; Lin PH; Nitin ; Kuo CW; Rodrigues E; Bhattacherjee A; Raeisimakiani P; Daskhan GC; St Laurent CD; Khoo KH; Mahal LK; Zandberg WF; Huang X; Klassen JS; Macauley MS
ACS Chem Biol; 2021 Nov; 16(11):2673-2689. PubMed ID: 34661385
[TBL] [Abstract][Full Text] [Related]
11. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
van de Wall S; Santegoets KCM; van Houtum EJH; Büll C; Adema GJ
Trends Immunol; 2020 Apr; 41(4):274-285. PubMed ID: 32139317
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Analysis of Siglec Ligands by Flow Cytometry.
Chang LY; Sridharan D; Angata T
Curr Protoc; 2023 Dec; 3(12):e949. PubMed ID: 38050649
[TBL] [Abstract][Full Text] [Related]
13. Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation.
Movsisyan LD; Macauley MS
Org Biomol Chem; 2020 Aug; 18(30):5784-5797. PubMed ID: 32756649
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Recombinant Siglecs and Identification of Their Ligands.
Chang LY; Low PY; Sridharan D; Gerlovin K; Angata T
Methods Mol Biol; 2020; 2132():85-98. PubMed ID: 32306317
[TBL] [Abstract][Full Text] [Related]
15. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
16. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
Linnartz-Gerlach B; Mathews M; Neumann H
Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
[TBL] [Abstract][Full Text] [Related]
17. Human sialoglycan ligands for immune inhibitory Siglecs.
Gonzalez-Gil A; Li TA; Kim J; Schnaar RL
Mol Aspects Med; 2023 Apr; 90():101110. PubMed ID: 35965135
[TBL] [Abstract][Full Text] [Related]
18. Sialoside analogue arrays for rapid identification of high affinity siglec ligands.
Blixt O; Han S; Liao L; Zeng Y; Hoffmann J; Futakawa S; Paulson JC
J Am Chem Soc; 2008 May; 130(21):6680-1. PubMed ID: 18452295
[TBL] [Abstract][Full Text] [Related]
19. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
Tsubata T
Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
[TBL] [Abstract][Full Text] [Related]
20. Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.
O'Sullivan JA; Youngblood BA; Schleimer RP; Bochner BS
Semin Immunol; 2023 Sep; 69():101799. PubMed ID: 37413923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]